Stroke Trial, Recruiting (NCT07271342)

Stroke Trial, Recruiting NCT07271342 Sponsor: Beijing Tiantan Hospital Condition: Stroke

Printed from Voxsanity (voxsanity.com.au) — NCT07271342 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Stroke

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You must be 18 years old or older
You must have been diagnosed with an acute ischemic stroke (a stroke caused by a blocked blood vessel) confirmed by a brain scan such as a CT or MRI
You must have received a clot-busting medication called tenecteplase, given through a drip, at the hospital taking part in the trial
You or a legally appointed representative must have signed a consent form agreeing to take part
You must be able to attend and complete follow-up appointments or assessments after the trial

Who may not be able to join:

You may not be able to join if you received any stroke treatment to restore blood flow (such as a clot-busting drug) before arriving at the hospital
You may not be able to join if you are already taking part in another clinical trial where the treatment involved could affect the results of this study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 2 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07271342

Sponsor: Beijing Tiantan Hospital

Phase: Not Applicable

Status: Recruiting

Condition: Stroke

More information: https://clinicaltrials.gov/study/NCT07271342

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You must be 18 years old or older
You must have been diagnosed with an acute ischemic stroke (a stroke caused by a blocked blood vessel) confirmed by a brain scan such as a CT or MRI
You must have received a clot-busting medication called tenecteplase, given through a drip, at the hospital taking part in the trial
You or a legally appointed representative must have signed a consent form agreeing to take part
You must be able to attend and complete follow-up appointments or assessments after the trial

Who may not be able to join:

You may not be able to join if you received any stroke treatment to restore blood flow (such as a clot-busting drug) before arriving at the hospital
You may not be able to join if you are already taking part in another clinical trial where the treatment involved could affect the results of this study

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 2 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Beijing Tiantan Hospital

Registry

ClinicalTrials.gov

Start date

30 November 2025

Est. completion

31 March 2029

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Favorable functional outcome at 90 days (modified Rankin Scale [mRS] score ≤1)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 2 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov